ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2026
Regional research priorities for medication safety and pharmacovigilance in gulf cooperation council countries: a modified Delphi consensus study.
Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Adverse drug reactions (ADRs) and medication errors remain major global threats to patient safety. Although Gulf Cooperation Council (GCC) countries have advanced medication safety and pharmacovigilance programs, research priorities remain fragmented and lack expert consensus. To establish consensus on medication safety and pharmacovigilance research priorities across GCC countries using a modified Delphi approach. A two-round, web-based modified Delphi study was conducted between November 2024 and September 2025. Experts from Saudi Arabia, Qatar, Oman, Kuwait, Bahrain, and the United Arab Emirates were recruited based on professional experience. Participants rated research priorities using a 9-point Likert scale. Consensus was defined as ≥ 80% of participants rating an item 7-9 and < 15% rating it 1-3. Quantitative data were analysed descriptively, and qualitative feedback informed item refinement. A total of 38 experts completed both Delphi rounds (response rate: 79.2%). In Round 1, 30 out of 47 priorities (63.8%) achieved consensus. In Round 2, five additional items reached consensus, resulting in a final set of 35 priorities (74.5%). The highest agreement was observed in the Healthcare Professionals domain (100%), followed by Medicines (77.8%), Patients and the Public (72.7%), and Systems and Practices (69.6%). Key priorities included addressing inappropriate polypharmacy, improving human factors and system design, enhancing patient safety at home, and strengthening reporting and surveillance systems. This Delphi study identified regional research priorities to guide medication safety and pharmacovigilance efforts across the GCC. The findings offer a structured research agenda to inform policy, funding decisions, and institutional strategies, while supporting global patient safety goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.